Revenue

Biotech Immunome plans a massive stock offering. A deep dive into the high-stakes bet on its cancer pipeline and what it means for investors.

Boise Cascade's acquisition of Holden Humphrey aims to reshape the Northeast building materials market, consolidating its power and expanding its product lines.

A $1.2M investment isn't just charity; it's a strategic push for 'whole-person health' aimed at fixing the Pacific Northwest's deepest care gaps.

Ford hits the brakes on its aggressive EV plan, pivoting to profitable hybrids and a bold new venture in battery energy storage. What does this mean?

IO Biotech’s cancer vaccine posts impressive 5-year survival data, but a narrow miss in its pivotal trial creates an uncertain path in a competitive market.

Beyond a routine board re-election, Heidmar Maritime is doubling down on an AI-driven strategy to navigate the volatile tanker market. Here's what it means.

Kodiak Sciences is raising crucial capital with a stock offering, diluting investors but fueling its late-stage retinal drugs. Is this a necessary lifeline or a red flag?

A modest dividend payout belies a massive ambition. Canterbury Park is betting its future not on the track, but on building an entire community around it.

Verastem Oncology taps industry heavyweights for its leadership, signaling a bold new strategy to accelerate its cancer pipeline and grow its market share.

Tiziana's CEO doubles down with a major share purchase, signaling deep faith in a novel MS drug, even as market signals send mixed messages.

Beijing touts its Sanjiangyuan project as a win for ecology and herders. But beyond the state narrative lies a complex story of coercion and cultural risk.

A new report forecasts modest 2.6% growth for US construction in 2026, driven by data centers, water, and aviation, but challenged by major hurdles.

In a volatile market, Edupoint's award-winning SIS proves that steady integration and fiscal discipline can deliver more resilient returns than fleeting trends.

Mitchell Silberberg & Knupp's new partners reveal a deeper trend: how elite firms are cultivating specialized talent to win in a changing legal market.

A popular countertop choice is fueling a deadly, incurable lung disease among workers, sparking a public health crisis and a race for safer alternatives.

New rankings name Germany's top cancer hospitals, but the real story is the rise of platforms shaping a multi-billion dollar global health market.

As the year-long TRANSFORMERS crossover ends, we analyze the strategy, tech, and financial impact of a new benchmark in mobile gaming partnerships.

While some public services face cuts, a Colorado library is expanding. We explore the strategy behind this counter-trend investment in community.

NineDot Energy is leveraging battery storage to deliver $60M in energy credits, tackling NYC's affordability crisis and retiring polluting power plants.

CMS's new ACCESS model spotlights virtual care, positioning firms like FlyteHealth to lead a tech-driven transformation in managing chronic illness.